The FDA issued draft guidance for industry, titled “Use of Data Monitoring Committees in Clinical Trials,” to assist sponsors of…
Read MoreBy Erin D. Solomon, PhD The 2018 updates to the Common Rule emphasize the importance of participants understanding the information…
Read MoreBy Elena Ghanaim and Jonathan Lawson The NIH Data Management and Sharing (DMS) Policy is a watershed moment for the…
Read MoreBy Emily E. Anderson, Stephanie Solomon Cargill, and Ryan Spellecy Engaging communities in research beyond mere enrollment is not new…
Read More